Clinical Trial Update: PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. [Phase 1]

View source ↗

Summary

Phase 1 study assessing the fluorine-18 labeled PET tracer BAY86-9596 for PET/CT imaging in patients with cancer or inflammatory conditions; the trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Inflammatory Diseases

Drugs mentioned

• BAY86-9596 (18F) (BAY86-9596)

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Diagnostic Imaging | Phase 1 | Status: COMPLETED